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Abstract
Diamond-Blackfan Anemia (DBA) is a congenital erythroid aplasia characterized as a
normochromic macrocytic anemia with a selective deficiency in red blood cell precursors in
otherwise normocelullar bone marrow. DBA is known to be associated with mental retardation
and learning disabilities. Although comorbidities with other psychiatric conditions have not been
reported in the existing literature, we report in this paper a case of a DBA patient with previously
undiagnosed comorbidity of obsessive compulsive disorder (OCD), successfully treated with
sertaline 200 mg/day and valproic acid 600 mg/day. This case of comorbid presentation has clinical,
therapeutic and pathophysiological implications. Given the difficulty of distinguishing among mental
retardation, learning disabilities and OCD and the importance of precocious diagnosis in treating
OCD especially since there are treatment methods interfering with anemia symptoms, physicians
should adapt an adequate screening tool treating a child with DBA and comorbid mental disorder.
Introduction
Diamond-Blackfan Anemia (DBA) is a congenital disease,
charactereized by a defective erythroid progenitor matura-
tion and is associated with physical malformations.
Majority of cases are sporadic and dominant with 10% of
the patients demonstrating recessive inheritance.
Mutations in the gene encoding for ribosomal protein
RPS19 (DBA1) have been found in 25% of patients with
either the dominant or the sporadic traits [1,2].
It is noteworthy that these mutations are associated with
mental retardation as well as with learning disabilities in
DBA patients [1,3].
Somatic abnormalities have been found in 47% of the
patients registered with the DBA Registry of North Amer-
ica [4,5].
Associated physical anomalies and growth retardation are
common and outstanding even in patients with multifac-
torial etiology such as long term steroid treatment [3].
The combination of clinical and molecular findings sug-
gests a contiguous gene syndrome with a gene focus for
mental retardation and skeletal malformations.
Repetitive and stereotyped behaviors are as common as
mental retardation and in some cases their manifestations
reach the threshold for diagnosis of obsessive compulsive
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disorder (OCD) (according to the Diagnostic Statistical
Manual of Mental Disease IV edition Text Revised DSM-IV
TR criteria) [6].
In the following case we present a DBA patient with
comorbidity of OCD. This case has tremendous signifi-
cance due to the demonstration of the clinical and the
pathophysiologic as well as therapeutic implications,
involved in the assessment of behavioral abnormalities in
DBA.
Case presentation
L. is a 22 year old Italian male, diagnosed with DBA at the
age of two. Since being diagnosed with DBA, L has been
treated with monthly blood transfusions and subcutane-
ous injections of deferoxamine mesylate. Years later, he
developed iatrogenic hepatitis due to multiple blood
transfusions. Despite attending a special education pro-
gram for children with learning disabilities, the patient
has experienced major difficulties in carrying out daily
activities since the age of six. He showed attention deficit
at school, social isolation and, since the age of 12, verbal
and motor repetitive behaviors, apparently cyclically
worsening during mood instability episodes.
L was reluctant to speak about his repetitive behaviors. L's
parents attributed their child's behaviours to the develop-
mental disabilities. A standard psychiatric diagnosis was
not reached, no treatment was established during child-
hood.
L' s grandfather was diagnosed with OCD (checking com-
pulsions) in comorbidity with an Impulsive Control Dis-
order (Intermittent Explosive Disorders), his
grandmother was depressed and alcohol addict.
At the age of sixteen the patient had an episode of herpetic
encephalitis with symptoms of delirium and therefore, he
was treated for two years with carbamazepine. One year
later he was diagnosed with polyendocrinopathy of
hypothyroidism, hypoparathyroidism and hypogonad-
ism. The encephalitis process had no consequences. Nei-
ther mental state nor cognition alteration were reported
following the episode.
At the age of twenty one repetitive behaviors increased in
frequency to a level that required psychiatric attention and
pharmacological management. Trying to address both
mood symptoms and repetitive behaviors, a treatment
with low doses of olanzapine and venlafaxine was estab-
lished, with no improvement in symptoms and a strong
deterioration of patient's anemia. L was hospitalized and
a more thorough psychiatric assessment was conducted.
The patient is in the lower normal range of height (164
cm) and IQ (87). He complained of impulsive sexual and
aggressive thoughts that were intrusive, repetitive and dis-
tressing. He also complained of compulsive behaviors
and rituals, such as hoarding, arranging, ordering, preoc-
cupations with symmetry, exactness, rewriting and doubt-
ing. Interrupting the patient while carrying out his rituals
lead to violence. The patient had moderate insight of his
illness.
He fulfilled the DSM-IV TR criteria for OCD and diagnosis
was established by the Structural Clinical Interview for
DSM-IV Axis I Disorders (SCID-I) [7]. In order to deter-
mine the severity level of obsessive compulsive symp-
toms, the Yale Brown Obsessive Compulsive scale
(YBOCS) [8], a clinician rated 10 item scale, each rated
from 0 (no symptoms) to 4 (extremely severe symptoms),
was performed on him and revealed a score of 28, which
corresponds to a severe form. A treatment with sertaline
200 mg/day (addressing OCD symptoms) and valproic
acid 600 mg/day (with the aim of reducing the impulsive
features linked to obsessions and according to its efficacy
reported in treatment of DBA) [9] has been started.
In the meantime an MRI exam was done as well and it
showed low signal areas due to accumulation of paramag-
netic substances in the right temporal lobe and in the ven-
tricular choroid plexus, asymmetric sphenoid sinus and
hypoplastic pituitary gland. Sellar region and parasellar
structures appeared in a regular pattern. No anomalies in
encephalic parenchyma were demonstrated after contrast
medium injection.
The patient was assessed 12 weeks after the administra-
tion of the YBOCS and demonstrated an improved total
score of 15, which corresponds to a mild form of OCD
with a reduction of more than 45% of the symptoms.
Discussion
For the first time we have described DBA with comorbid
OCD. The above described case could demonstrate heu-
ristically valuable clinical, therapeutic and pathophysio-
logical implications if more DBA patients with comorbid
OCD would be screened by hematologists and therefore
deserves further discussion.
There is a great importance in the assessment of obsessive-
compulsive symptoms in DBA patients with mental or
behavioral disturbances. Since OCD often goes undiag-
nosed in the presence of more pervasive disturbances
[10], our report assumes a "Caveat" value.
Distinguishing between mental retardation, learning disa-
bilities, Asperger Syndrome and OCD can be challenging,
especially when treating children. Precocious diagnosis ofClinical Practice and Epidemiology in Mental Health 2008, 4:6 http://www.cpementalhealth.com/content/4/1/6
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OCD can make a tremendous difference in terms of evo-
lutionary trajectory and improved life quality of patients
and their families.
Pediatricians should bear in mind the possibility of OCD
when treating DBA children with behavioralor learning
disabilities even in the absence of other malformations.
It has been shown that when adequate screening tools
were adopted in clinical disciplines other than psychiatry
(for instance in dermatology and immunology), a larger
than expected number of undiagnosed OCD patients was
revealed [11].
Also, OCD is potentially linked to brain iron accumula-
tion in DBA. Studies done in animals demonstrated that
brain iron accumulation leads to damage of neuronal
dopaminergic function.
Intranigral iron injection in rats have shown a detrimental
effect on dopamine (DA) release and concentration in the
caudate putamen (CPu) as well as selective decrease of
striatal dopamine (95%), 3,4-dihydroxyphenylacetic acid
serotogenic activity (82%), and homovanillic acid (45%)
with related behavioral changes, characterized by
increased repetitive and compulsive behaviors.
Thus, hemosiderosis might be contributing to psychiatric
symptoms in DBA patients [12]. In fact, OCD symptoms
may be linked to hemosiderin deposition in the brain and
the pituitary gland, just as hypopituitarism has been
shown to be linked to hemosiderin deposition in the pitu-
itary as it was hypothesized previously by Berdel [13,14].
Moreover, since OCD has been related also to multiple
regions of cortical thinning [15], the MRI imaging in our
case of paramagnetic substance accumulation in the right
temporal lobe, ventricular plexus and the hypoplastic
pituitary gland is suggestive of the importance of neu-
roimaging assessment and recognition of complications
caused by iron deposition due to long term blood transfu-
sions in the management of DBA.
However a conclusion can not be drawn without a verifi-
cation through larger studies on populations that have
undergone blood transfusions at a young age.
Presenting this case report we have shown that OCD
symptoms are treatable in DBA as effectively as in other
conditions such as mental retardation [16] and Down
Syndrome [17].
Despite the fact that some psychiatric medications have
shown a worsening of the symptoms of anemia, SSRIs and
valproate have been extremely beneficial and safe.
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